To understand the mechanism underlying the delayed mammary tumor development in B1P2p mice, we asked whether combined loss of BRCA1 and PALB2 would cause synthetic lethality in MECs, thereby reducing their overall tumorigenic potential. Here, PALB2 is linked to breast cancer.